Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection

Zorginstituut Nederland carried out an assessment of the medicine tenofovir alafenamide (Vemlidy®). Based on the criteria of the Medicines Reimbursement System (GVS), tenofovir alafenamide fumarate (TAF) is interchangeable with tenofovir disoproxil fumarate (TDF), which is included on List 1B of the GVS.